20th Annual NATA Symposium Scientific Programme

Scientific Programme

Thursday, April 4, 2019

MORNING

8:45-9:00 Welcome address
Charles-Marc Samama, Paris, France
 

Hall BC

PATIENT BLOOD MANAGEMENT
– PAST, PRESENT AND FUTURE

Charles-Marc Samama, Paris, France
Konrad Messmer, Munich, Germany


9:00-9:20 An anniversary NATA symposium – looking back on 20 years of PBM education
Jean-François Baron, Paris, France

9:20-9:40 PBM: an unproven concept? ‒ the Frankfurt consensus conference
Erhard Seifried, Frankfurt, Germany

9:40-10:00 PBM: the standard of care!
Aryeh Shander, Englewood, NJ, USA

10:00-10:30 Discussion

10:30-11:10 Break and poster visits


Hall BC

PATIENT BLOOD MANAGEMENT IN SURGERY
– PREOPERATIVE PREPARATION

Manuel Muñoz, Málaga, Spain
Lutz Kaufner, Berlin, Germany


11:10-11:25 How to get started and overcome barriers to implementation?
Jean-François Hardy, Montreal, QC, Canada

11:25-11:40 Anaemia and iron deficiency screening and evaluation: a practical approach
Elvira Bisbe, Barcelona, Spain

11:40-11:55 Preoperative iron supplementation – when and how should it be done?
Toby Richards, Perth, WA, Australia

11:55-12:10 Is there a role for EPO in preoperative preparation?
Sigismond Lasocki, Angers, France

12:10-12:40 Discussion


Hall A

PATIENT BLOOD MANAGEMENT
– DOES IT WORK IN CHILDREN TOO?

Beverley J. Hunt, London, UK
Sherri Ozawa, Englewood, NJ, USA


11:10-11:30 Perioperative transfusion triggers – all the same as in adults?
Philippe Van der Linden, Brussels, Belgium

11:30-11:50 Factor concentrates in paediatrics – top or flop?
Thorsten Haas, Zurich, Switzerland

11:50-12:10 PBM in paediatric cardiac surgery: NATA guidelines
David Faraoni, Toronto, ON, Canada

12:10-12:40 Discussion



12:40-13:50 Lunchtime industry-sponsored satellite symposia and workshops

13:50-14:30 Break and poster visits


Thursday, April 4, 2019

AFTERNOON

Hall BC

IRON THERAPY IN SPECIAL INDICATIONS

Toby Richards, Perth, WA, Australia
Thomas Frietsch, Mannheim, Germany


14:30-14:45 Iron deficiency: causes, global burden and treatment options
Axel Hofmann, Zurich, Switzerland

14:45-15:00 Iron therapy in patients with cancer – ESMO clinical practice guidelines
Yves Beguin, Liège, Belgium

15:00-15:15 Iron therapy in obstetrics – a global public health challenge
Bernd Froessler, Adelaide, SA, Australia

15:15-15:30 The revival of oral iron: new agents, new dosing regimens
Manuel Muñoz, Málaga, Spain

15:30-16:00 Discussion


Hall A

UNDERRATED MEASURES
IN PATIENT BLOOD MANAGEMENT

Elvira Bisbe, Barcelona, Spain
Beverley J. Hunt, London, UK


14:30-14:45 The role of the surgeon in PBM
Mike Reed, Newcastle upon Tyne, UK

14:45-15:00 Tranexamic acid – still underrated?
Beverley J. Hunt, London, UK

15:00-15:15 Is haemodynamic monitoring a necessary cornerstone of PBM?
Christian von Heymann, Berlin, Germany

15:15-15:30 PBM measures in low-income countries
Tina Tomić Mahečić, Zagreb, Croatia

15:30-16:00 Discussion

16:00-16:40 Break and poster visits


Hall BC

EMERGENCY CARE OF PATIENTS
RECEIVING ANTITHROMBOTICS

Charles-Marc Samama, Paris, France
Oliver Grottke, Aachen, Germany


16:40-16:55 Assessing drug-induced bleeding risk and severity
Jerrold H. Levy, Durham, NC, USA

16:55-17:10 Bleeding and emergency procedures in patients on vitamin K antagonists
Beverley J. Hunt, London, UK

17:10-17:25 Bleeding and emergency procedures in patients on direct oral anticoagulants
Charles-Marc Samama, Paris, France

17:25-17:40 Bleeding and emergency procedures in patients on antiplatelet agents
David Faraoni, Toronto, ON, Canada

17:40-18:10 Discussion


Hall A

BEST POSTERS
– PRESENTATIONS AND AWARDS

Jens Meier, Linz, Austria
Manuel Muñoz, Málaga, Spain


16:40-16:48 Case study of blood recycling device, Hemafuse, in urban Kenyan surgical theatres
Katherine Kirsch, Nairobi, Kenya

16:48-16:56 Do coagulation profiles change in vitro and in vivo post re-infusion of autologous blood collected during caesarean section?
Timothy Tagell, Truro, UK

16:56-17:04 First trimester haemoglobin and maternal morbidity: a prospective cohort study with multivariable analysis
Jahnavi Daru, London, UK

17:04-17:12 Calculation of risks associated with preoperative anaemia and the health-economic footprint of patient blood management
Thomas Drabinski, Kiel, Germany

17:12-17:20 Pooled analysis of the PHOSPHARE-IDA 04/05 studies: findings relevant to respiratory muscle function
Heinz Zoller, Innsbruck, Austria

17:20-17:28 Efficacy and safety of fibrinogen concentrate vs cryoprecipitate in pseudomyxoma peritonei surgery: a prospective, randomised, controlled phase 2 study
Faheez Mohamed, Basingstoke, UK

17:28-17:36 Pharmacokinetics of enoxaparin after coronary artery bypass grafting. Randomised clinical trial
Maria Parviainen, Tampere, Finland

17:36-17:44 Impact of direct oral anticoagulant therapy on the management of hip fracture patients
Nicolas Gautier, Charleroi, Belgium

17:44-18:10 Poster awards


Friday, April 5, 2019

MORNING

Hall BC

RED BLOOD CELL TRANSFUSION
– HOW LOW CAN/SHOULD WE GO?

Jean-François Hardy, Montreal, QC, Canada
Peter Schlenke, Graz, Austria


9:00-9:20 Is continuous haemoglobin measurement useful?
Azriel Perel, Tel Aviv, Israel

9:20-9:40 Anaemia tolerance in patients with coronary heart disease
Marco Ranucci, Milan, Italy

9:40-10:00 Anaemia tolerance in elderly patients
Jens Meier, Linz, Austria

10:00-10:30 Discussion


Hall A

ANTICOAGULATION

David Faraoni, Toronto, ON, Canada
Beverley J. Hunt, London, UK


9:00-9:20 Coagulopathy of sepsis – time to reconsider anticoagulants?
Jerrold H. Levy, Durham, NC, USA

9:20-9:40 Hospital-acquired thrombosis: a major patient safety issue
Beverley J. Hunt, London, UK

9:40-10:00 VTE prevention: what do the guidelines say?
Charles-Marc Samama, Paris, France

10:00-10:30 Discussion

10:30-11:10 Break and poster visits


Hall BC

STOP THE BLEEDING!

Charles-Marc Samama, Paris, France
Donat R. Spahn, Zurich, Switzerland


11:10-11:30 Fibrinogen or plasma in trauma – which way to go?
Herbert Schöchl, Vienna, Austria

11:30-11:50 Fibrinogen in high-blood-loss surgery – a must?
Faheez Mohamed, Basingstoke, UK

11:50-12:10 Modern coagulation management – possible without POC devices?
Thorsten Haas, Zurich, Switzerland

12:10-12:40 Discussion


Hall A

SAFETY OF BLOOD AND BLOOD PRODUCTS

José A. García-Erce, Pamplona, Spain
Axel Pruss, Berlin, Germany


11:10-11:25 Age of blood: do we have all the answers?
Arturo Pereira Saavedra, Barcelona, Spain

11:25-11:40 Which plasma to use in bleeding?
Rainer Moog, Cottbus, Germany

11:40-11:55 Blood safety issues – what should be tested in 2019?
Peter Schlenke, Graz, Austria

11:55-12:10 Transfusion-associated circulatory overload: increased awareness is needed
Alexander Vlaar, Amsterdam, The Netherlands

12:10-12:40 Discussion



12:40-13:50 Lunchtime industry-sponsored satellite symposia and workshops

13:50-14:30 Break and poster visits


Friday, April 5, 2019

AFTERNOON

Hall BC

BREAKING NEWS

Jens Meier, Linz, Austria
Marco Ranucci, Milan, Italy


14:30-14:50 Treatment of preoperative anaemia in cardiac surgery
Donat R. Spahn, Zurich, Switzerland

14:50-15:10 Hepcidin – the new golden bullet for iron therapy?
Sigismond Lasocki, Angers, France

15:10-15:30 Management of postpartum haemorrhage – NATA consensus statement
Jean-François Hardy, Montreal, QC, Canada

15:30-16:00 Discussion


16:00 Concluding comments
Charles-Marc Samama, Paris, France